Published in Nature on October 01, 1998
Synthetic multivalent ligands as probes of signal transduction. Angew Chem Int Ed Engl (2006) 3.29
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A (2008) 2.21
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci U S A (2001) 2.00
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine (2008) 1.95
Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci U S A (1999) 1.86
Structural interactions of fibroblast growth factor receptor with its ligands. Proc Natl Acad Sci U S A (2000) 1.76
Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer (2001) 1.72
Erythropoietin derived by chemical synthesis. Science (2013) 1.66
Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure (2010) 1.63
The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry (2007) 1.51
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions. EMBO J (2003) 1.46
Receptor recognition by gp130 cytokines. EMBO J (2000) 1.46
The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol (2010) 1.44
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol (2012) 1.41
Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A (2006) 1.41
Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci U S A (1999) 1.40
Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med (2008) 1.36
Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J (2000) 1.34
Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci U S A (2002) 1.32
Nonnatural protein-protein interaction-pair design by key residues grafting. Proc Natl Acad Sci U S A (2007) 1.30
Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol (2006) 1.29
Erythropoietin. Cold Spring Harb Perspect Med (2013) 1.28
Core erythropoietin receptor signals for late erythroblast development. Blood (2005) 1.26
Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun (2011) 1.14
Hypoxia alters progression of the erythroid program. Exp Hematol (2007) 1.04
Molecular mechanisms of prolactin and its receptor. Endocr Rev (2012) 1.04
Wiggle-predicting functionally flexible regions from primary sequence. PLoS Comput Biol (2006) 1.03
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell (2015) 1.02
Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries. Proc Natl Acad Sci U S A (2012) 1.02
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med (2010) 1.02
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Sci U S A (2004) 1.00
Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. FASEB J (2011) 1.00
Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex. Mol Cell (2009) 1.00
Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes. J Biol Chem (2010) 0.99
The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling. J Mol Biol (2007) 0.99
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs. EMBO J (2011) 0.99
The effect of erythropoietin on normal and neoplastic cells. Biologics (2012) 0.98
Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization. Protein Sci (2003) 0.98
Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions. Future Med Chem (2011) 0.96
Mimicry of erythropoietin by a nonpeptide molecule. Proc Natl Acad Sci U S A (1999) 0.95
Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain. EMBO J (1999) 0.95
The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. Proc Natl Acad Sci U S A (2004) 0.95
Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. Biochem J (2000) 0.95
Insulin receptor activation with transmembrane domain ligands. J Biol Chem (2014) 0.94
Convergent chemical synthesis of [lysine(24,38,83)] human erythropoietin. Angew Chem Int Ed Engl (2011) 0.93
A common model for cytokine receptor activation: combined scissor-like rotation and self-rotation of receptor dimer induced by class I cytokine. PLoS Comput Biol (2012) 0.92
Optimization of CD4/gp120 inhibitors by thermodynamic-guided alanine-scanning mutagenesis. Chem Biol Drug Des (2013) 0.92
Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. Biochem J (2001) 0.92
Structure-based redesign of proteins for minimal T-cell epitope content. J Comput Chem (2013) 0.92
Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration. Hum Mol Genet (2011) 0.89
Transmembrane helix-helix interactions involved in ErbB receptor signaling. Cell Adh Migr (2010) 0.89
Rationalizing 5000-fold differences in receptor-binding rate constants of four cytokines. Biophys J (2011) 0.89
Understanding cytokine and growth factor receptor activation mechanisms. Crit Rev Biochem Mol Biol (2012) 0.88
The erythropoietin receptor: molecular structure and hematopoietic signaling pathways. J Investig Med (2011) 0.88
Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol (2014) 0.87
An antibody CDR3-erythropoietin fusion protein. ACS Chem Biol (2013) 0.87
Design of growth factor sequestering biomaterials. Chem Commun (Camb) (2014) 0.87
Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86
A model of the ternary complex of interleukin-10 with its soluble receptors. BMC Struct Biol (2005) 0.86
Rotamer optimization for protein design through MAP estimation and problem-size reduction. J Comput Chem (2009) 0.86
Erythropoietin in brain development and beyond. Anat Res Int (2012) 0.86
JAK2 activation by growth hormone and other cytokines. Biochem J (2015) 0.85
Structural insight into the transmembrane domain and the juxtamembrane region of the erythropoietin receptor in micelles. Biophys J (2014) 0.84
Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin. Int J Nanomedicine (2011) 0.84
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Eur J Clin Pharmacol (2010) 0.84
Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. Exp Hematol (2006) 0.84
Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Exp Hematol (2003) 0.84
Identification of the residues in the extracellular domain of thrombopoietin receptor involved in the binding of thrombopoietin and a nuclear distribution protein (human NUDC). J Biol Chem (2010) 0.83
An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation. Proc Natl Acad Sci U S A (2007) 0.83
Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor. Biochem J (2005) 0.83
Multifarious determinants of cytokine receptor signaling specificity. Adv Immunol (2014) 0.83
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor. J Biol Chem (2015) 0.83
Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Proc Natl Acad Sci U S A (1999) 0.82
Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch. Nucleic Acids Res (2003) 0.82
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor. Biochemistry (2010) 0.81
Progress in detecting cell-surface protein receptors: the erythropoietin receptor example. Ann Hematol (2013) 0.81
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency. Sci Signal (2015) 0.80
Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care. Crit Care (2012) 0.80
Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS analysis. Mol Cells (2014) 0.79
PCFamily: a web server for searching homologous protein complexes. Nucleic Acids Res (2010) 0.79
Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell (2015) 0.79
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell (2017) 0.78
New therapeutic strategies targeting transmembrane signal transduction in the immune system. Cell Adh Migr (2010) 0.78
Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review. Eur J Clin Pharmacol (2011) 0.78
Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptor. Protein Sci (1999) 0.78
The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin. PLoS One (2015) 0.77
The SCHOOL of nature: III. From mechanistic understanding to novel therapies. Self Nonself (2010) 0.77
Do All X-ray Structures of Protein-Ligand Complexes Represent Functional States? EPOR, a Case Study. Biophys J (2017) 0.76
A Miniature Protein Stabilized by a Cation-π Interaction Network. J Am Chem Soc (2016) 0.76
The role of interchain heterodisulfide formation in activation of the human common beta and mouse betaIL-3 receptors. J Biol Chem (2010) 0.76
Identification of the disulfide bonds of lysyl oxidase. J Neural Transm (Vienna) (2010) 0.75
Improved drug-like properties of therapeutic proteins by directed evolution. Protein Eng Des Sel (2012) 0.75
Antagonism of activin by activin chimeras. Vitam Horm (2011) 0.75
Cellular level models as tools for cytokine design. Biotechnol Prog (2010) 0.75
The development of an affinity evaluation and prediction system by using protein-protein docking simulations and parameter tuning. Adv Appl Bioinform Chem (2009) 0.75
C-Terminally fused affinity Strep-tag II is removed by proteolysis from recombinant human erythropoietin expressed in transgenic tobacco plants. Plant Cell Rep (2014) 0.75
Mapping the homodimer interface of an optimized, artificial, transmembrane protein activator of the human erythropoietin receptor. PLoS One (2014) 0.75
An extra high dose of erythropoietin fails to support the proliferation of erythropoietin dependent cell lines. Cytotechnology (2011) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
The sequence of the human genome. Science (2001) 101.55
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Comparative genomics of the eukaryotes. Science (2000) 26.62
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Analyzing high-density oligonucleotide gene expression array data. J Cell Biochem (2000) 16.73
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl (2001) 8.50
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet (1999) 8.17
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74
Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science (2000) 7.53
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52
Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell (1994) 7.43
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
Structure of a glycerol-conducting channel and the basis for its selectivity. Science (2000) 6.64
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Epitaxial BiFeO3 multiferroic thin film heterostructures. Science (2003) 6.14
A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet (1995) 5.87
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab (2001) 5.76
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
Structural origins of high-affinity biotin binding to streptavidin. Science (1989) 5.37
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell (1999) 5.28
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res (1995) 5.26
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell (2001) 5.19
Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (2000) 5.14
Crystal structure of a MAT alpha 2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions. Cell (1991) 5.14
Expression of naphthalene oxidation genes in Escherichia coli results in the biosynthesis of indigo. Science (1983) 5.10
Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol (1971) 5.06
A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature (1995) 4.93
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology (2001) 4.84
Specific inhibition of Stat3 signal transduction by PIAS3. Science (1997) 4.74
Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc Natl Acad Sci U S A (1984) 4.70
Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science (1999) 4.69
HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev (2000) 4.67
The signal recognition particle. Annu Rev Biochem (2001) 4.47
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev (2001) 4.47
The wheat and barley vernalization gene VRN3 is an orthologue of FT. Proc Natl Acad Sci U S A (2006) 4.38
Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1998) 4.33
Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A (2001) 4.30
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology (2007) 4.24
Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry (1992) 4.19
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res (1996) 4.11
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med (1996) 4.07
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature (2000) 4.00
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A (1992) 3.91
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci (2001) 3.85
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther (2003) 3.85
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A (1999) 3.82
Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol (2009) 3.81
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem (1998) 3.77
T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med (2000) 3.76
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene (2009) 3.64
Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int (2006) 3.64
A local alignment tool for very long DNA sequences. Comput Appl Biosci (1995) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet (2001) 3.48
A diverse new primate fauna from middle Eocene fissure-fillings in southeastern China. Nature (1994) 3.46
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A (1999) 3.43
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev (1994) 3.40
Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet (1999) 3.39
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev (2000) 3.38
Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell (1995) 3.37
Sequences of genes encoding naphthalene dioxygenase in Pseudomonas putida strains G7 and NCIB 9816-4. Gene (1993) 3.33
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther (2000) 3.32
Rapid elimination of low-copy DNA sequences in polyploid wheat: a possible mechanism for differentiation of homoeologous chromosomes. Genetics (1997) 3.28
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc Natl Acad Sci U S A (2000) 3.26
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol (2000) 3.24
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Mutations of GTBP in genetically unstable cells. Science (1995) 3.23
TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol (2001) 3.22
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif (2012) 3.18
BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18
The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell (1999) 3.15
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol (1998) 3.13
A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem (1997) 3.12
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem (1999) 3.09
Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res (2001) 3.06
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05